BFM
HLVX

Boothbay Fund Management’s HilleVax HLVX Stock Holding History

Boothbay Fund Management’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,449
Closed -$114K – 2383
2022
Q2 		$114K Buy
+10,449
New +$124K ﹤0.01% 1953

Other funds holding HLVX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boothbay Fund Management's HLVX Position: Q3 2022 in Review

Boothbay Fund Management sold out of HilleVax (HLVX) in Q3 2022, closing a stake of 10,449 shares — an estimated $114K sold.

Boothbay Fund Management first reported a position in HLVX in Q2 2022 and held it in 1 quarter. The position peaked at $114K in Q2 2022. 51 funds tracked by Wall St. Rank hold HLVX as of Q3 2022.

  • Boothbay Fund Management reported no remaining HilleVax position as of Q3 2022 after selling out during the quarter.
  • Boothbay Fund Management sold 10,449 HilleVax shares in Q3 2022, an estimated $114K.
  • Boothbay Fund Management first reported a position in HilleVax in Q2 2022 and held it in 1 quarter.
  • Boothbay Fund Management's HilleVax position peaked at $114K in Q2 2022.
  • 51 funds tracked by Wall St. Rank held HilleVax as of Q3 2022.

Based on Boothbay Fund Management's 13F filing for Q3 2022, filed 14 Nov 2022.